www.photopharmics.com
Open in
urlscan Pro
54.196.30.232
Public Scan
Submitted URL: https://email.rdhgroups.co/c/eJwUyjtuxCAQANDTQLkahmFnKSjcuEiRO2A-AskOCLCs3D5K_6IzCTEpmZxi0BatUiyLC5Y5A0G0lI1JkI9IyUZPHN8qHF...
Effective URL: https://www.photopharmics.com/
Submission: On January 02 via api from US — Scanned from DE
Effective URL: https://www.photopharmics.com/
Submission: On January 02 via api from US — Scanned from DE
Form analysis
0 forms found in the DOMText Content
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked. Accept Decline * Follow * Follow * Follow * Follow * Clinical Pathway * Science * Patient Experience * Leadership * Newsroom * Investors * Clinical Pathway * Science * Patient Experience * Leadership * Newsroom * Investors Video Player 00:03 00:00 00:21 Use Up/Down Arrow keys to increase or decrease volume. A PERSONALIZED, AT-HOME BREAKTHROUGH One of the most significant treatments for Parkinson’s disease in decades ADDRESSING MAJOR UNMET NEEDS IN PARKINSON'S With large improvements from robust clinical studies PIVOTAL TRIAL TO CONFIRM SUSTAINED EFFICACY Initiating remote trial of Celeste Specialized Phototherapy NEWS – FDA GRANTS BREAKTHROUGH DESIGNATION FOR CELESTE® SPECIALIZED PHOTOTHERAPY. Learn more about Celeste specialized phototherapy as the only light-related therapy to receive this FDA recognition. Be among the first to know when our pivotal study recruiting begins. Sign Up > NEWS – FDA GRANTS BREAKTHROUGH DESIGNATION FOR SPECIALIZED PHOTOTHERAPY. Learn more about Celeste specialized phototherapy as the only light-related therapy to receive this FDA recognition. Be among the first to know when our pivotal study recruiting begins. Sign Up > ADDRESSING MAJOR UNMET NEEDS A BREAKTHROUGH THERAPY FOR PEOPLE LIVING WITH PARKINSON’S DISEASE Specialized phototherapy addresses both motor and non-motor symptoms Over 11 million people worldwide live with Parkinson’s disease (PD), a number that is projected to double over the next 20 years. As with so many other neurodegenerative diseases, there have been no major breakthroughs in Parkinson’s disease in decades. Our personalized at-home device promises to be one of the most significant therapeutic breakthroughs in Parkinson’s disease in decades. We have seen large improvements in our proof-of-concept studies – especially in addressing major unmet needs in Parkinson’s. We are initiating a pivotal trial of our key product, Celeste® specialized phototherapy, to confirm safety and sustained efficacy. Despite the efficacy of dopaminergic drugs, people with PD continue to experience difficulties with unresolved motor symptoms and non-motor symptoms (e.g., sleep disorders, fatigue, and mood and cognitive problems). Impaired function significantly reduces quality of life for many, often preventing those living with PD from working, exercising, socializing, and doing the things they want to do. We invite you to join us to improve the lives of individuals suffering from neurodegenerative diseases. Investor Inquiries Do you or someone you know suffer with Parkinson’s? Click here for patient information. SEEING SPECIALIZED PHOTOTHERAPY CLEARLY Our non-invasive specialized phototherapy is well on its way to becoming a physician-prescribed standard of care. When it comes to motor and non-motor symptoms of Parkinson’s, here’s what we’re seeing so far. PROMISING RESULTS Research participants experienced large, clinically meaningful improvements in combined motor and non-motor function and enjoyed improved quality of life. NON-INVASIVE Those who added specialized phototherapy to their existing drug regimen experienced no major device-related side-effects or negative interactions with their current prescriptions. LIFESTYLE FRIENDLY PROTOCOL Research participants found our device safe and convenient to use while watching TV, reading, using a smart phone, or other seated activities. More About Our Clinical Success IMPROVING LIFE FOR PEOPLE WITH NEURODEGENERATIVE DISEASES While our first focus is Parkinson’s, we aim to extend our therapeutic platform to Alzheimer’s and other neurodegenerative diseases, promising relief and even healing for millions. Join us in improving lives by supporting our innovation and participating in our clinical research Stay Connected TRENDING TOPICS INNOVATIVE RESEARCH, INCLUSIVE TRIALS, AND NEW FUNDING DRIVES HOPE FOR PEOPLE WITH PARKINSON’S DISEASE Nov 15, 2023 Innovative Research, Inclusive Trials, and New Funding Drives Hope for People with Parkinson's Disease PhotoPharmics Secures $16 Million Investment Led by Kickstart to Fund Pivotal Clinical Trial for FDA Market Authorization PhotoPharmics, an innovator in Parkinson's... CELESTE® LIGHT FOR PD TRIAL TO BE PRESENTED AT WORLD PARKINSON’S CONGRESS Jun 22, 2023 Celeste® Light for PD Trial to be Presented at World Parkinson’s Congress PhotoPharmics to showcase groundbreaking research at the prestigious international event July 5-7, 2023 PhotoPharmics, a leading innovator in Parkinson's disease, today announced that it will be... PHOTOPHARMICS TO PRESENT AT MTI ALL STARS INVESTOR SHOWCASE May 10, 2023 PhotoPharmics to Present at MTI All Stars Investor Showcase DeviceTalks in Boston on May 10-11 to feature pitches from PhotoPharmics and other leading startups PhotoPharmics today announced CEO Kent Savage has been invited to present at the inaugural MTI All Stars... HOW PARKINSON’S AFFECTS SLEEP AND VICE-VERSA Mar 28, 2022 When most people think of Parkinson’s Disease (PD), the first symptom to come to mind are physical tremors and other movement symptoms. However, most people with Parkinson’s experience a wide range of non-motor symptoms that can often be more disruptive to their daily... CARE FOR THE CAREGIVERS Nov 18, 2021 “What would I do without my caregiver?” Many people with Parkinson’s disease ask themselves some form of this question every single day. Caregivers come in all shapes and forms, but they all have one thing in common: The work they do is absolutely critical. But it’s... QUICK LINKS * Contact Us * Investors * Newsroom * Follow * Follow * Follow * Follow PHOTOPHARMICS, INC. 3451 North Triumph Boulevard, Suite 201 Lehi, UT 84043 USA Phone +1 (801) 770-6960 © 2023 PhotoPharmics. All Rights Reserved. | Privacy Policy | Terms of Use